These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 28583409)

  • 1. Portopulmonary hypertension and hepatorenal syndrome. Two faces of the same coin.
    Zardi EM; Zardi DM; Giorgi C; Chin D; Dobrina A
    Eur J Intern Med; 2017 Sep; 43():22-27. PubMed ID: 28583409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatorenal syndrome.
    Biswas KD; Jain AK
    Trop Gastroenterol; 2002; 23(3):113-6. PubMed ID: 12693150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatorenal syndrome.
    Kramer L; Hörl WH
    Semin Nephrol; 2002 Jul; 22(4):290-301. PubMed ID: 12118394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Critical care of the liver transplant patient: an update.
    McGilvray ID; Greig PD
    Curr Opin Crit Care; 2002 Apr; 8(2):178-82. PubMed ID: 12386521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulmonary complications in cirrhosis.
    Sussman NL; Kochar R; Fallon MB
    Curr Opin Organ Transplant; 2011 Jun; 16(3):281-8. PubMed ID: 21543981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review article: advances in the management of patients with cirrhosis and portal hypertension-related renal dysfunction.
    Leithead JA; Hayes PC; Ferguson JW
    Aliment Pharmacol Ther; 2014 Apr; 39(7):699-711. PubMed ID: 24528130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting circulatory dysfunction in cirrhosis: terlipressin and the hepatorenal syndrome.
    Testro AG; Angus PW
    J Gastroenterol Hepatol; 2009 Nov; 24(11):1707-9. PubMed ID: 20136956
    [No Abstract]   [Full Text] [Related]  

  • 8. Advances in the pathogenesis and treatment of type-1 and type-2 hepatorenal syndrome.
    Arroyo V; Terra C; Ginès P
    J Hepatol; 2007 May; 46(5):935-46. PubMed ID: 17391801
    [No Abstract]   [Full Text] [Related]  

  • 9. Management of portopulmonary hypertension: new perspectives.
    Mancuso L; Scordato F; Pieri M; Valerio E; Mancuso A
    World J Gastroenterol; 2013 Dec; 19(45):8252-7. PubMed ID: 24363516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical aspects of portopulmonary hypertension.
    Medarov BI; Chopra A; Judson MA
    Respir Med; 2014 Jul; 108(7):943-54. PubMed ID: 24816204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatorenal syndrome.
    Guevara M; Ginès P
    Dig Dis; 2005; 23(1):47-55. PubMed ID: 15920325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular syndromes in liver cirrhosis.
    Shenoda B; Boselli J
    Clin J Gastroenterol; 2019 Oct; 12(5):387-397. PubMed ID: 30980261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pulmonary complications of hepatic cirrhosis: portopulmonary hypertension and hepatopulmonary syndrome. The paradox of pulmonary vasoconstriction and vasodilation].
    Chávez-Tapia NC; Uribe M; López E
    Gac Med Mex; 2007; 143(4):333-9. PubMed ID: 17969842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel use of sildenafil in the treatment of portopulmonary hypertension.
    Chua R; Keogh A; Miyashita M
    J Heart Lung Transplant; 2005 Apr; 24(4):498-500. PubMed ID: 15797756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Portopulmonary hypertension.
    Krowka MJ
    Semin Respir Crit Care Med; 2012 Feb; 33(1):17-25. PubMed ID: 22447257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging hepatic syndromes: pathophysiology, diagnosis and treatment.
    Bertino G; Privitera G; Purrello F; Demma S; Crisafulli E; Spadaro L; Koukias N; Tsochatzis EA
    Intern Emerg Med; 2016 Oct; 11(7):905-16. PubMed ID: 27273018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of hepatorenal syndrome and liver transplantation.
    Memon I; Klein CL
    Curr Opin Organ Transplant; 2011 Jun; 16(3):301-5. PubMed ID: 21505341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Portopulmonary Hypertension and Liver Transplant: Recent Review of the Literature.
    Cosarderelioglu C; Cosar AM; Gurakar M; Pustavoitau A; Russell SD; Dagher NN; Gurakar A
    Exp Clin Transplant; 2016 Apr; 14(2):113-20. PubMed ID: 27015528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coexisting hepatopulmonary syndrome and portopulmonary hypertension: implications for liver transplantation.
    Pham DM; Subramanian R; Parekh S
    J Clin Gastroenterol; 2010 Aug; 44(7):e136-40. PubMed ID: 20463591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic options in pulmonary hepatic vascular diseases.
    Horvatits T; Fuhrmann V
    Expert Rev Clin Pharmacol; 2014 Jan; 7(1):31-42. PubMed ID: 24308785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.